Dr. Wenbo Wang extended a warm welcome to Professor Gascoigne and Dr. Ling Wu. Professor Gascoigne is an internationally renowned expert in T cell biology and the TCR field, with over thirty years of research

Recently, Dr. Wenbo Wang, CEO of Lealing Bio, attended the 9th Biocytogen Model Animal and Pharmaceutical Industry Conference as a keynote speaker. He delivered an insightful presentation titled “From Antibodies to TCRs: The Next Wave of Innovative Biologics.”

Recently, Lealing Biopharma (Suzhou) Co., Ltd. (“Lealing Bio”) announced the completion of an angel round financing worth tens of millions of RMB, co-invested by Bohe Angel Fund and Yuanbio Venture Capital. The raised funds will